Insys Therapeutics, Inc. (INSY) Monday said the U.S. Food and Drug Administration has granted orphan drug status to the company's pharmaceutical cannabidiol for treating glioma, a common type of malignant brain tumor.
CEO Michael Babich said the company will focus initially on pontine glioma (a tumor found in the brainstem), for which the company's pharmaceutical cannabidiol was granted orphan drug designation last month.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.